What Makes Us Different?
We use small datasets to achieve drug discovery and development without the cost of a large infrastructure. As a result, we are able to cut costs and expedite the development timeline.
Optim.AI does not rely on in silico, or synergy prediction-based methods for identifying combinations.
We use actionable, real-time data from experimental/clinical studies to design research interrogation rationally and efficiently
Optim.AI is disease mechanism-independent and use case-agnostic. As such, it can be rapidly adapted to a broad range of applications.
We identify the optimum in ingredients and dosage ratios simultaneously, resulting in globally optimal outputs.
Optim.AI Combination Discovery Process
Optimized for efficacy/toxicity
6-8 weeks In Vitro
Ranked by efficacy
Hundreds of experiments